NDC 68001-446

MEROPENEM

Meropenem

MEROPENEM is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Bluepoint Laboratories. The primary component is Meropenem.

Product ID68001-446_186e8e7c-0a2a-4e48-b5f7-a036f351ca5f
NDC68001-446
Product TypeHuman Prescription Drug
Proprietary NameMEROPENEM
Generic NameMeropenem
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2020-08-31
Marketing CategoryANDA / ANDA
Application NumberANDA206086
Labeler NameBluePoint Laboratories
Substance NameMEROPENEM
Active Ingredient Strength500 mg/20mL
Pharm ClassesCarbapenems [CS],Penem Antibacterial [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 68001-446-31

10 VIAL in 1 CARTON (68001-446-31) > 20 mL in 1 VIAL (68001-446-29)
Marketing Start Date2020-08-31
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "MEROPENEM" or generic name "Meropenem"

NDCBrand NameGeneric Name
0409-0222MeropenemMeropenem
0409-1390MeropenemMeropenem
0409-1391MeropenemMeropenem
0409-3412MeropenemMeropenem
0409-3505MeropenemMEROPENEM
0409-3506MeropenemMEROPENEM
0781-3000MEROPENEMMEROPENEM
0781-3098MEROPENEMMEROPENEM
0781-3265MeropenemMeropenem
0781-3267MeropenemMeropenem
25021-155Meropenemmeropenem
25021-156Meropenemmeropenem
44567-145MeropenemMeropenem
68001-324MeropenemMeropenem
68001-323MeropenemMeropenem
68083-147MeropenemMeropenem
68083-146MeropenemMeropenem
70278-103MeropenemMeropenem
70121-1453MeropenemMeropenem
70121-1454MeropenemMeropenem
70278-104MeropenemMeropenem
44647-032MEROPENEMMEROPENEM
44647-033MEROPENEMMEROPENEM
55150-208MeropenemMeropenem
55150-207MeropenemMeropenem
63323-508MeropenemMeropenem
63323-507MeropenemMeropenem
0069-0313MERREMMeropenem
0069-0314MERREMMeropenem
0310-0321MERREMMeropenem
0310-0325MERREMMeropenem
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.